Mark Durkan – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Mark Durkan on 2015-11-13.

To ask the Secretary of State for Health, if he will ensure that any new system of appraisal for cancer medicines will include in its remit appraisal for drugs which treat conditions with small patient populations.

George Freeman

NHS England has advised that it intends to jointly consult with the National Institute for Health and Care Excellence on proposals for a new Cancer Drugs Fund operating model. This will include the future arrangements for the evaluation of cancer drugs, including drugs for rarer cancers with small patient populations. Members of the public and any interested parties will have the opportunity to consider and comment on these proposals.